Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2010
11/23/2010US7838537 Viral polymerase inhibitors
11/23/2010US7838536 delivers zinc to cancer cells or zinc chelation within the cancer cells using the unbound ligand; bioavailability; with texaphyrin metal complex;
11/23/2010US7838530 Antiproliferative agent in the prevention or treatment of tumors which are sensitive to inhibition of EGF and erbB receptor tyrosine kinases;1-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}methyl)-L-prolinamide
11/23/2010US7838527 Methods of treating cancer and related methods
11/23/2010US7838525 modulators of glucose metabolism, GPCR, RUP3; metabolic disorders and complications thereof such as diabetes and obesity; 4-[5-Cyano-6-(6-methylsulfanyl-pyridin-3-ylamino)-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid tert-butyl ester
11/23/2010US7838524 Substituted pyrazolyl urea derivatives useful in the treatment of cancer
11/23/2010US7838523 [5-(Pyridin-2-ylamino)-6-oxo-1,6-dihydro-pyridin-3-yl]-(3-amido)-benzene derivatives; anticarcinogenic, antiproliferative, antiallergen, and antiinflammatory agents; lymphoma, leukemia, autoimmune diseases; Bruton's tyrosine kinase inhibitors
11/23/2010US7838521 phosphodiesterase PDE4 inhibitor; preparing claimed 3-(dialkoxy)phenyl-4-aminopyran intermediate from the claimed 4-oxo compound starting with hydrobromination of the corresponding phenylacetylene; antiinflammatory for airways and skin; respiratory; bronchodilator
11/23/2010US7838520 Inhibitors of histone deacetylase
11/23/2010US7838518 1-(4-methoxynaphthalene-1-sulfonyl)-2,3-dihydro-1H-indole-3-carboxylic acid [2-(1-methyl-pyrrolidin-2-yl)-ethyl]amide; selective affinity for 5-HT6 receptor; psychosis, schizophrenia, depression, neurological disorders, cognitive enhancement, Parkinson's disease, ALS, Alzheimer's, Huntington's disease
11/23/2010US7838299 use of the complexes obtained as fluorescent markers, and as relaxation agents for NMR or for NMR imaging
11/23/2010US7838127 Organic light emitters having as a charge transfer compound, forexample, zirconium complex of 2-methyl-4-trifluoromethyl-8-hydroxyquinoline; also titaniumcomplexes; also electron transport layers
11/23/2010CA2496295C Novels pyrazole compounds as transforming growth factor (tgf) inhibitors
11/23/2010CA2487489C Mitotic kinesin inhibitors
11/23/2010CA2480239C Method for manufacture of sertindole
11/23/2010CA2459380C Reverse hydroxamic acid derivatives
11/23/2010CA2377309C Compounds for the modulation of ppar.gamma. activity
11/23/2010CA2342200C Use of certain drugs for treating nerve root injury
11/18/2010WO2010132873A2 Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthase
11/18/2010WO2010132601A1 Antiviral compounds
11/18/2010WO2010132598A1 Heteroaryl compounds as pikk inhibitors
11/18/2010WO2010132524A1 2-azatriphenylene materials for organic light emitting diodes
11/18/2010WO2010132247A1 Benzimidazole derivatives useful as trp m8 receptor modulators
11/18/2010WO2010131738A1 Azetidine compound and medicinal use thereof
11/18/2010WO2010131147A1 Cyclobutenedione derivatives
11/18/2010WO2010131146A1 Cyclobutenedione derivatives
11/18/2010WO2010131145A1 Cyclobutenedione derivatives
11/18/2010WO2010131030A1 Pyridylurea derivatives and their therapeutic use
11/18/2010WO2010130945A1 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof, and therapeutic use thereof
11/18/2010WO2010130943A1 5-membered heterocyclic compound cyclopenta[c]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof
11/18/2010WO2010130900A2 Triaminopyrimidine derivatives as cdc25 phosphatase inhibitors
11/18/2010WO2010130794A1 5-pyridin-3-yl-1,3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or cyp11b1
11/18/2010WO2010130767A2 Fungicide pyrazole carboxamides derivatives
11/18/2010WO2010130718A1 Process for the preparation of a compound useful as an inhibitor of tafia
11/18/2010WO2010130638A1 Sulfonamide compounds, pharmaceutical compositions and uses thereof
11/18/2010WO2010130178A1 Acrylamide derivative and use thereof in manufacture of medicament
11/18/2010WO2010130034A1 Inhibitors of human immunodeficiency virus replication
11/18/2010WO2010059611A3 Inhibitors of diacylglycerol acyltransferase
11/18/2010WO2010036613A8 Novel cyclic benzimidazole derivatives useful anti-diabetic agents
11/18/2010WO2010034838A3 Antiproliferative compounds
11/18/2010WO2010033168A3 Modulators of p2x3 receptor activity
11/18/2010WO2009156735A3 New therapeutic agents
11/18/2010WO2009149858A8 Novel heteroaromatic amides and thioamides as pesticides
11/18/2010WO2009124733A8 Substituted sulfonamide derivatives
11/18/2010US20100292484 Chiral Pyrrolidine Core Compounds en route to Inhibitors of Nitric Oxide Synthase
11/18/2010US20100292483 Tetrazoyloxime derivative and plant disease control agent
11/18/2010US20100292481 Method for producing conjugated aromatic compound
11/18/2010US20100292276 Benzimidazole derivatives useful as trp m8 receptor modulators
11/18/2010US20100292274 Haloalkyl heteroaryl benzamide compounds
11/18/2010US20100292263 Cgrp receptor antagonists with tertiary amide, sulfonamide, carbamite and urea groups
11/18/2010US20100292259 Pyrimidyl indoline compound
11/18/2010US20100292258 Substituted aromatic heterocyclic compounds as fungicides
11/18/2010US20100292252 Vinyl-aryl derivatives for inflammation and immune-related uses
11/18/2010US20100292251 Montelukast benzhydryl piperazine salts and process for preparation thereof
11/18/2010US20100292247 Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents
11/18/2010US20100292242 Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
11/18/2010US20100292234 Triazole fused heteroaryl compounds and methods of use thereof
11/18/2010US20100292231 Indazole Compounds for Treating Inflammatory Disorders, Demyelinating Disorders and Cancers
11/18/2010US20100292227 Inhibitors of human immunodeficiency virus replication
11/18/2010US20100292225 Aryl pyridine as aldosterone synthase inhibitors
11/18/2010US20100292219 Tertiary amine substituted peptides useful as inhibitors of hcv replication
11/18/2010US20100292215 11beta-hydroxysteroid dehydrogenase type 1 active compounds
11/18/2010US20100292214 Compounds with Antiparasitic Activity, Applications thereof to the Treatment of Infectious Diseases Caused by Apicomplexans
11/18/2010US20100292206 Heterocyclic compound
11/18/2010US20100292205 Pyrimidone Compounds As GSK-3 Inhibitors
11/18/2010US20100292187 Methods for treating hepatitis c
11/18/2010US20100292183 Tetracycline and uses thereof
11/18/2010US20100288634 Transition Metal Complexes with Bidentate Ligand Having an Imidazole Ring
11/18/2010CA2762036A1 Inhibitors of human immunodeficiency virus replication
11/18/2010CA2761858A1 5-pyridin-3-yl-1,3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or cyp11b1
11/18/2010CA2761663A1 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof, and therapeutic use thereof
11/18/2010CA2761658A1 5-membered heterocyclic compound cyclopenta[c]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof
11/18/2010CA2761269A1 Fungicide pyrazole carboxamides derivatives
11/18/2010CA2761258A1 Antiviral compounds
11/18/2010CA2760778A1 Heteroaryl compounds as pikk inhibitors
11/18/2010CA2760748A1 Process for the preparation of a compound useful as an inhibitor of tafia
11/17/2010EP2251338A2 Organic compounds
11/17/2010EP2251337A1 Dihydropyridine calcium antagonist compounds, preparation methods and medical uses thereof
11/17/2010EP2251336A1 Hydrazide compounds as intermediates of pesticides
11/17/2010EP2251331A1 Fungicide pyrazole carboxamides derivatives
11/17/2010EP2251327A2 Heterocyclic inhibitors of MEK and methods of use thereof
11/17/2010EP2251326A1 Heterocyclic compound
11/17/2010EP2250162A2 Amide derivatives as positive allosteric modulators and methods of use thereof
11/17/2010EP2250161A1 Compounds having crth2 antagonist activity
11/17/2010EP2250155A1 5h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors
11/17/2010EP2250152A1 Quinolines as inhibitors of farnesyl pyrophosphate synthase
11/17/2010EP2249832A1 Method for treating fibrosis and cancer with imidazolium and imidazolinium compounds
11/17/2010EP2249650A1 Anilinopyridines as inhibitors of fak
11/17/2010EP2170260B1 Azo derivatives containing a pyrazolinone unit for dyeing keratin fibres
11/17/2010EP1928861B1 4- (ih-indazol-5-yl-amino)-quinazoline compounds as erbb receptor tyrosine kinase inhibitors for the treatment of cancer
11/17/2010EP1907860B1 Mass labels
11/17/2010EP1899296B1 Histamine-3 receptor antagonists
11/17/2010EP1778671B1 Piperazine derivatives with ccr3 inhibiting activity
11/17/2010EP1585522B1 Quinazolinones as potassium channel modulators
11/17/2010EP1476428B1 Pyridyl sulfone derivatives as 5-ht6 receptor ligands
11/17/2010EP0773940B2 Process for synthesis of substituted sulphoxides
11/17/2010CN1810803B Method for high enantiomer selection preparation of (S)-Omeprazole
11/17/2010CN101889009A Inhibitors of c-fms kinase
11/17/2010CN101889008A Quinoline derivatives for modulating DNA methylation
11/17/2010CN101889004A Inhibitors of protein kinases
1 ... 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 ... 1080